159 related articles for article (PubMed ID: 27999837)
21. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
Shi Y; Goodisman J; Dabrowiak JC
Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy.
Saraswathy M; Knight GT; Pilla S; Ashton RS; Gong S
Colloids Surf B Biointerfaces; 2015 Feb; 126():590-597. PubMed ID: 25591850
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
24. Mitochondria-targeting zeolitic imidazole frameworks to overcome platinum-resistant ovarian cancer.
Xing Y; Jiang Z; Akakuru OU; He Y; Li A; Li J; Wu A
Colloids Surf B Biointerfaces; 2020 May; 189():110837. PubMed ID: 32058250
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
26. The Cisplatin, 5-fluorouracil, Irinotecan, and Gemcitabine Treatment in Resistant 2D and 3D Model Triple Negative Breast Cancer Cell Line: ABCG2 Expression Data.
Ata FK; Yalcin S
Anticancer Agents Med Chem; 2022; 22(2):371-377. PubMed ID: 34315389
[TBL] [Abstract][Full Text] [Related]
27. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
Yu H; Gou S; Wang Z; Chen F; Fang L
Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
[TBL] [Abstract][Full Text] [Related]
28. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles.
Ganesh S; Iyer AK; Gattacceca F; Morrissey DV; Amiji MM
J Control Release; 2013 Dec; 172(3):699-706. PubMed ID: 24161254
[TBL] [Abstract][Full Text] [Related]
29. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
[TBL] [Abstract][Full Text] [Related]
30. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
31. pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer.
Cao Z; Li W; Liu R; Li C; Song Y; Liu G; Chen Y; Lu C; Lu A; Liu Y
Int J Nanomedicine; 2020; 15():8369-8382. PubMed ID: 33149581
[TBL] [Abstract][Full Text] [Related]
32. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
Bae KH; Tan S; Yamashita A; Ang WX; Gao SJ; Wang S; Chung JE; Kurisawa M
Biomaterials; 2017 Dec; 148():41-53. PubMed ID: 28961534
[TBL] [Abstract][Full Text] [Related]
34. A photo-controlled hyaluronan-based drug delivery nanosystem for cancer therapy.
Sun F; Zhang P; Liu Y; Lu C; Qiu Y; Mu H; Duan J
Carbohydr Polym; 2019 Feb; 206():309-318. PubMed ID: 30553327
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.
Xie Y; Aillon KL; Cai S; Christian JM; Davies NM; Berkland CJ; Forrest ML
Int J Pharm; 2010 Jun; 392(1-2):156-63. PubMed ID: 20363303
[TBL] [Abstract][Full Text] [Related]
36. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
[TBL] [Abstract][Full Text] [Related]
37. Phospholipid-chitosan hybrid nanoliposomes promoting cell entry for drug delivery against cervical cancer.
Saesoo S; Bunthot S; Sajomsang W; Gonil P; Phunpee S; Songkhum P; Laohhasurayotin K; Wutikhun T; Yata T; Ruktanonchai UR; Saengkrit N
J Colloid Interface Sci; 2016 Oct; 480():240-248. PubMed ID: 27442151
[TBL] [Abstract][Full Text] [Related]
38. Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6.
Nukolova NV; Baklaushev VP; Abakumova TO; Mel'nikov PA; Abakumov MA; Yusubalieva GM; Bychkov DA; Kabanov AV; Chekhonin VP
Bull Exp Biol Med; 2014 Aug; 157(4):524-9. PubMed ID: 25110098
[TBL] [Abstract][Full Text] [Related]
39. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
[TBL] [Abstract][Full Text] [Related]
40. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation.
Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
Colloids Surf B Biointerfaces; 2014 Nov; 123():600-9. PubMed ID: 25454761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
